Synopsis
Synopsis
0
KDMF
0
VMF
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Cellcristin
2. Citomid
3. Farmistin
4. Leurocristine
5. Oncovin
6. Oncovine
7. Onkocristin
8. Pfs, Vincasar
9. Sulfate, Vincristine
10. Vincasar
11. Vincasar Pfs
12. Vincristin Bristol
13. Vincristin Medac
14. Vincristine
15. Vincrisul
16. Vintec
1. 2068-78-2
2. Kyocristine
3. Vincristine Sulphate
4. Vincrisul
5. Leurocristine Sulfate
6. Oncovin
7. Onkovin
8. Marqibo
9. 22-oxovincaleukoblastine Sulfate
10. Vcr Sulfate
11. Rel-vincristine Sulfate
12. Nsc 67574
13. Lilly 37231
14. Nsc67574
15. Nsc-67574
16. Leurocristine, Sulfate (1:1) (salt)
17. Alkaloid Extracted From Vinca Rosea Linn
18. Novopharm
19. Chebi:79401
20. 1217704-93-2
21. Mls002702994
22. Lilly-37231
23. Vincristini Sulfas
24. Oncovin (lilly)
25. Vincasar (tn)
26. Marqibo (tn)
27. Oncovin (tn)
28. Vincrex (tn)
29. Vincristine, Sulfate
30. Leurocristine, Sulfate
31. Vincristine Sulphate Salt
32. Vincristine Sulfate Liposome
33. Schembl3710
34. Leurocristine Sulfate (1:1)
35. Chembl501867
36. Dtxsid8044331
37. Vincristine Sulfate (jp17/usp)
38. Hms3414l13
39. Hms3678l11
40. Mfcd08706469
41. Akos015895862
42. V0129
43. Lcr
44. Vcr
45. D02197
46. 068v782
47. A936684
48. Methyl (3ar,3a1r,4r,5s,5ar,10br)-4-acetoxy-3a-ethyl-9-((3s,5s,7s,9s)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-1,4,5,6,7,8,9,10-octahydro-2h-3,7-methano[1]azacycloundecino[5,4-b]indol-9-yl)-6-formyl-5-hydroxy-8-methoxy-3a,3a1,4,5,5a,6,11,12-octahydro-1h-indolizino[8,1-cd]carbazole-5-carboxylate Sulfate
Molecular Weight | 923.0 g/mol |
---|---|
Molecular Formula | C46H58N4O14S |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 16 |
Rotatable Bond Count | 10 |
Exact Mass | 922.36702371 g/mol |
Monoisotopic Mass | 922.36702371 g/mol |
Topological Polar Surface Area | 254 Ų |
Heavy Atom Count | 65 |
Formal Charge | 0 |
Complexity | 1830 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 9 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Marqibo kit |
Active Ingredient | Vincristine sulfate |
Dosage Form | Injectable, liposomal |
Route | Intravenous |
Strength | 5mg/5ml (1mg/ml) |
Market Status | Prescription |
Company | Talon Therap |
2 of 4 | |
---|---|
Drug Name | Vincristine sulfate pfs |
Active Ingredient | Vincristine sulfate |
Dosage Form | Injectable |
Route | Injection |
Strength | 1mg/ml |
Market Status | Prescription |
Company | Hospira; Teva Pharms Usa |
3 of 4 | |
---|---|
Drug Name | Marqibo kit |
Active Ingredient | Vincristine sulfate |
Dosage Form | Injectable, liposomal |
Route | Intravenous |
Strength | 5mg/5ml (1mg/ml) |
Market Status | Prescription |
Company | Talon Therap |
4 of 4 | |
---|---|
Drug Name | Vincristine sulfate pfs |
Active Ingredient | Vincristine sulfate |
Dosage Form | Injectable |
Route | Injection |
Strength | 1mg/ml |
Market Status | Prescription |
Company | Hospira; Teva Pharms Usa |
Antineoplastic Agents, Phytogenic
Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)
Tubulin Modulators
Agents that interact with TUBULIN to inhibit or promote polymerization of MICROTUBULES. (See all compounds classified as Tubulin Modulators.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
31
PharmaCompass offers a list of Vincristine Sulfate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Vincristine Sulfate manufacturer or Vincristine Sulfate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Vincristine Sulfate manufacturer or Vincristine Sulfate supplier.
PharmaCompass also assists you with knowing the Vincristine Sulfate API Price utilized in the formulation of products. Vincristine Sulfate API Price is not always fixed or binding as the Vincristine Sulfate Price is obtained through a variety of data sources. The Vincristine Sulfate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Vincristine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vincristine, including repackagers and relabelers. The FDA regulates Vincristine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vincristine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Vincristine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Vincristine supplier is an individual or a company that provides Vincristine active pharmaceutical ingredient (API) or Vincristine finished formulations upon request. The Vincristine suppliers may include Vincristine API manufacturers, exporters, distributors and traders.
click here to find a list of Vincristine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Vincristine DMF (Drug Master File) is a document detailing the whole manufacturing process of Vincristine active pharmaceutical ingredient (API) in detail. Different forms of Vincristine DMFs exist exist since differing nations have different regulations, such as Vincristine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Vincristine DMF submitted to regulatory agencies in the US is known as a USDMF. Vincristine USDMF includes data on Vincristine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Vincristine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Vincristine suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Vincristine Drug Master File in Japan (Vincristine JDMF) empowers Vincristine API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Vincristine JDMF during the approval evaluation for pharmaceutical products. At the time of Vincristine JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Vincristine suppliers with JDMF on PharmaCompass.
A Vincristine CEP of the European Pharmacopoeia monograph is often referred to as a Vincristine Certificate of Suitability (COS). The purpose of a Vincristine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Vincristine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Vincristine to their clients by showing that a Vincristine CEP has been issued for it. The manufacturer submits a Vincristine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Vincristine CEP holder for the record. Additionally, the data presented in the Vincristine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Vincristine DMF.
A Vincristine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Vincristine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Vincristine suppliers with CEP (COS) on PharmaCompass.
A Vincristine written confirmation (Vincristine WC) is an official document issued by a regulatory agency to a Vincristine manufacturer, verifying that the manufacturing facility of a Vincristine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Vincristine APIs or Vincristine finished pharmaceutical products to another nation, regulatory agencies frequently require a Vincristine WC (written confirmation) as part of the regulatory process.
click here to find a list of Vincristine suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Vincristine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Vincristine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Vincristine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Vincristine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Vincristine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Vincristine suppliers with NDC on PharmaCompass.
Vincristine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Vincristine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Vincristine GMP manufacturer or Vincristine GMP API supplier for your needs.
A Vincristine CoA (Certificate of Analysis) is a formal document that attests to Vincristine's compliance with Vincristine specifications and serves as a tool for batch-level quality control.
Vincristine CoA mostly includes findings from lab analyses of a specific batch. For each Vincristine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Vincristine may be tested according to a variety of international standards, such as European Pharmacopoeia (Vincristine EP), Vincristine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vincristine USP).